Eratrectinib
Eratrectinib (Example 1) is a Trk inhibitor. Eratrectinib can be studied in research for tropomyosin receptor kinase-related diseases and cancers[1].
Product Specifications
UNSPSC
12352005
Target
Trk Receptor
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
FC(C=C1[C@]2([H])N(CCC2)C3=NC4=C5C=NN4C=C3)=CN=C1CCN(C6CC6)NC5=O
Molecular Formula
C21H22FN7O
Molecular Weight
407.44
References & Citations
[1]Yong Wu, et al., Pyrazolo[1,5-a]pyrimidine derivatives as tropomyosin receptor kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2019233461A1.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-177082/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2396516-98-4]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15157911 1 Vial
Lentiviral mouse Gipc3 shRNA (UAS) - Lentiviral mouse Gipc3 shRNA (UAS, iRFP) (100)
Ask
View Details 